Melanocortin receptor-specific peptides for treatment of sexual dysfunction
    2.
    发明授权
    Melanocortin receptor-specific peptides for treatment of sexual dysfunction 有权
    用于治疗性功能障碍的黑皮质素受体特异性肽

    公开(公告)号:US08487073B2

    公开(公告)日:2013-07-16

    申请号:US12952238

    申请日:2010-11-23

    IPC分类号: A61K38/00

    摘要: A melanocortin receptor agonist cyclic peptide of the formula where R, x and y are as defined in the specification, compositions and formulations including the peptide of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including sexual dysfunction such as male erectile dysfunction and female sexual dysfunction.

    摘要翻译: 下式的黑皮质素受体激动剂环肽其中R,x和y如说明书中所定义,包括上述式的肽的组合物和制剂,以及预防,改善或治疗黑皮质素受体介导的疾病,适应症,条件 和综合征,包括性功能障碍如男性勃起功能障碍和女性性功能障碍。

    Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669
    3.
    发明申请
    Melanocortin Receptor-Specific Peptides for Treatment of Obesity / 669 审中-公开
    黑皮质素受体特异性肽用于治疗肥胖/ 669

    公开(公告)号:US20090305960A1

    公开(公告)日:2009-12-10

    申请号:US12480420

    申请日:2009-06-08

    IPC分类号: A61K38/12 C07K7/64 A61P3/00

    CPC分类号: C07K7/54 A61K38/00 C07K7/06

    摘要: Melanocortin receptor-specific cyclic peptides of the formula where R1, R2, R3, R4, x and y are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, diabetes, modulation of feeding behavior and related metabolic syndrome.

    摘要翻译: 其中R1,R2,R3,R4,x和y如说明书中所定义的组合物和制剂,包括上述式的肽的黑皮质素受体特异性环肽,以及预防,改善或治疗黑皮质素受体 - 介导的疾病,适应症,病症和综合症,包括肥胖症,糖尿病,调节摄食行为和相关的代谢综合征。

    Lactam-bridged melanocortin receptor-specific peptides
    4.
    发明授权
    Lactam-bridged melanocortin receptor-specific peptides 有权
    内酰胺桥接的黑皮质素受体特异性肽

    公开(公告)号:US09273098B2

    公开(公告)日:2016-03-01

    申请号:US13311817

    申请日:2011-12-06

    申请人: Xin Chen Wei Yang

    发明人: Xin Chen Wei Yang

    摘要: Lactam-bridged melanocortin receptor-specific cyclic peptides of the formula where R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, modulation of feeding behavior, related metabolic syndrome, sexual dysfunction, male erectile dysfunction and female sexual dysfunction.

    摘要翻译: R1,R2,R3,R4,R5,R6,R7,R8和R9如说明书中所定义的内酰胺交联的黑皮质素受体特异性环肽,包括上述式的肽的组合物和制剂以及方法 预防,改善或治疗黑皮质素受体介导的疾病,适应症,病症和综合征,包括肥胖症,调节进食行为,相关代谢综合征,性功能障碍,男性勃起功能障碍和女性性功能障碍。

    Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction
    5.
    发明申请
    Melanocortin Receptor-Specific Peptides for Treatment of Sexual Dysfunction 有权
    用于治疗性功能障碍的黑皮质素受体特异性肽

    公开(公告)号:US20110065652A1

    公开(公告)日:2011-03-17

    申请号:US12952238

    申请日:2010-11-23

    IPC分类号: A61K38/12 C07K7/00 A61P15/00

    摘要: A melanocortin receptor agonist cyclic peptide of the formula where R, x and y are as defined in the specification, compositions and formulations including the peptide of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including sexual dysfunction such as male erectile dysfunction and female sexual dysfunction.

    摘要翻译: 下式的黑皮质素受体激动剂环肽其中R,x和y如说明书中所定义,包括上述式的肽的组合物和制剂,以及预防,改善或治疗黑皮质素受体介导的疾病,适应症,条件 和综合征,包括性功能障碍如男性勃起功能障碍和女性性功能障碍。

    Lactam-Bridged Melanocortin Receptor-Specific Peptides
    7.
    发明申请
    Lactam-Bridged Melanocortin Receptor-Specific Peptides 有权
    内酰胺桥接的黑皮质素受体特异性肽

    公开(公告)号:US20120077957A1

    公开(公告)日:2012-03-29

    申请号:US13311817

    申请日:2011-12-06

    申请人: Xin Chen Wei Yang

    发明人: Xin Chen Wei Yang

    IPC分类号: C07K7/54

    摘要: Lactam-bridged melanocortin receptor-specific cyclic peptides of the formula where R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, modulation of feeding behavior, related metabolic syndrome, sexual dysfunction, male erectile dysfunction and female sexual dysfunction.

    摘要翻译: R1,R2,R3,R4,R5,R6,R7,R8和R9如说明书中所定义的内酰胺交联的黑皮质素受体特异性环肽,包括上述式的肽的组合物和制剂以及方法 预防,改善或治疗黑皮质素受体介导的疾病,适应症,病症和综合征,包括肥胖症,调节进食行为,相关代谢综合征,性功能障碍,男性勃起功能障碍和女性性功能障碍。

    POWER MANAGEMENT IN COMPUTING DEVICES
    9.
    发明申请
    POWER MANAGEMENT IN COMPUTING DEVICES 审中-公开
    计算设备中的电源管理

    公开(公告)号:US20160216756A1

    公开(公告)日:2016-07-28

    申请号:US14916853

    申请日:2013-11-29

    IPC分类号: G06F1/32

    摘要: Various techniques for modifying an operating state of a processor are described herein. In one example, an electronic device includes logic that can determine that a processor cannot modify the operating state of the processor. In some embodiments, the logic can also detect an indication that the electronic device is to enter an idle state and store state information from the processor in a volatile memory device. The logic can also cause the processor to enter the idle state.

    摘要翻译: 这里描述了用于修改处理器的操作状态的各种技术。 在一个示例中,电子设备包括可以确定处理器不能修改处理器的操作状态的逻辑。 在一些实施例中,逻辑还可以检测电子设备将要进入空闲状态的指示,并将来自处理器的状态信息存储在易失性存储器设备中。 逻辑也可以使处理器进入空闲状态。